$1.595 billion is the valuation at which Thornton-based Forge Nano intends to enter the public markets, a figure that hinges on the assumption of zero shareholder redemptions. By choosing to merge with Archimedes Tech SPAC Partners II, the company is bypassing the traditional IPO route to secure a faster injection of capital. Follow the money: the transaction includes $100 million in fresh private placement funding, supplementing the $242 million currently held in trust by the special purpose acquisition company.
Scaling Atomic Precision
The core of this valuation rests on the company’s "Atomic Armor" platform, a proprietary application of atomic layer deposition. While the underlying science has existed for decades, Paul Lichty, co-founder and CEO, contends that his team’s innovation lies in accelerating the speed and lowering the cost of the process. Having spent years in the R&D phase since the company’s 2013 inception, the firm is transitioning from a period of building market acceptance to one of industrial scale. This pivot follows a previous fundraising round that brought in $82.2 million in commitments, providing the runway necessary to prove the technology’s utility in both commercial and defense sectors.
Geographic Expansion and Operational Headcount
The capital infusion is explicitly tied to an aggressive production roadmap. Currently, the company maintains a battery factory in Thornton employing approximately 130 people. The expansion plan centers on a new facility in Morrisville, N.C., where the company expects to employ roughly 200 people. This geographic diversification is essential to meeting the production demand that Lichty claims currently outstrips the company's existing capabilities. By moving into the semiconductor and lithium-ion battery markets, Forge Nano is betting that its ability to manipulate materials at the atomic level will provide a critical competitive advantage in the AI-driven chip market.
The Path to the Nasdaq
Upon the completion of the deal, the combined entity will operate as Forge Nano Inc., with its common stock slated to trade on the Nasdaq under the ticker NANO, and warrants under NANOW. The management team is set to remain unchanged, maintaining the leadership structure that transitioned the technology from a University of Colorado patent acquired in 2010 to a commercialized manufacturing platform. The success of this transition now rests on the deal clearing its final hurdles, with an expected close in the second half of this year.
Investor Implications
For those watching the intersection of advanced manufacturing and public equity, the primary signal to track will be the redemption rate of Archimedes II shareholders. A high volume of redemptions would diminish the cash pool, potentially forcing a recalibration of the company's expansion plans in North Carolina. Prospective investors should weigh the promised production growth against the inherent volatility of a SPAC-led market entry, particularly as Forge Nano moves from the testing phase into the capital-intensive reality of full-scale factory operations. The next reading of the company’s quarterly production output will determine whether the "Atomic Armor" technology can deliver the efficiency gains necessary to justify a billion-dollar-plus valuation in a cooling tech sector.
